Concepedia

Publication | Open Access

Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide

277

Citations

25

References

2007

Year

Abstract

Our large, multicenter trial showed that the non-stem-cell toxic DRC regimen is an active, well-tolerated treatment for symptomatic patients with WM.

References

YearCitations

Page 1